Search Results - claudia+palena

2 Results

Sort By:

Novel Human Immunogenic Epitopes of the Human Endogenous Retrovirus ERVMER34-1

Summary: The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for the clinical translation of novel peptide-based therapeutic cancer vaccines derived from ERVMER34-1, a human endogenous retrovirus (HERV) antigen, offering a unique opportunity to address a significant unmet need in the treatment of various carcinomas. Description...

Published: 9/29/2025 | Inventor(s): Jeffrey Schlom, Duane Hamilton, Claudia Palena, Renee Donahue

Keywords(s):

Category(s): TherapeuticArea > Immunology, TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Vaccines

Brachyury-directed Vaccine for the Prevention or Treatment of Cancers

Abstract: Tumor invasion and metastasis are the primary drivers of cancer-related mortality. Therapies that have an ability to specifically target invasive and/or metastatic cells are anticipated to have a significant impact in the clinical management of advanced cancers. Researchers at the NCI have developed a vaccine technology that stimulates the...

Published: 4/22/2025 | Inventor(s): Jeffrey Schlom, Claudia Palena

Keywords(s): Brachyury, CANCER VACCINE, Immunotherapy, T-CELLS, Transcription factor

Category(s): TherapeuticArea > Oncology, Collaboration Sought > Collaboration, TherapeuticArea > Immunology, Application > Vaccines, Collaboration Sought > Licensing